Korro Bio KRRO Cash Flow Statement (2018-2026)

NASDAQ KRRO
$12.80 -0.14 (-1.04%)
As of: Sep 10, 2026 · 2:10 PM EDT
Reported Financials

Korro Bio Quarterly Cash Flow Statement

Periods 32 quarters
Latest Jun 2026

Korro Bio reported cash from operations of -$16.99M and free cash flow of -$17.03M for the quarter ended Jun 2026, up 11.6% year over year. This cash flow statement covers 32 quarters of results from Sep 2018 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow Statement Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income
-25.16M-21.50M-23.39M-21.29M-19.55M6.19M-19.61M-17.65M-18.49M-25.43M-19.56M-21.83M-21.00M-3.60M-23.39M-25.77M-18.06M-26.11M-19.62M-18.92M
Depreciation and DepletionDep. & Depletion
0.36M
Share-based CompensationStock Comp.
7.28M5.16M6.61M6.07M5.75M-14.29M5.60M4.74M4.66M1.23M0.86M0.97M1.27M1.36M1.76M2.00M1.82M2.07M2.73M2.70M
Asset Writedowns and ImpairmentWritedown
15.00M
Cash from OperationsCash from Ops.
-15.02M-17.89M-17.34M-13.48M-11.80M-11.03M-19.69M-14.71M-11.77M-21.11M-21.89M-14.59M-16.09M-7.50M-24.45M-19.23M-17.18M-17.70M-16.07M-16.99M
Depreciation, Depletion & Amortization
Amortizatization of IntangiblesAmort. of Intangibles
0.14M0.07M0.01M0.00M0.17M0.99M0.62M0.34M0.08M0.05M0.02M-0.00M-0.00M
Depreciation & Amortization (CF)Dep. & Amort.
0.36M
Change in Working Capital
Change in ReceivablesChange Receivables
1.70M0.23M-0.83M-0.27M0.15M-0.97M
Change in Account PayablesChange Payables
0.45M-0.38M-0.43M1.23M-0.34M1.30M0.55M-0.20M-0.04M2.79M-2.58M2.08M-0.23M-0.60M0.10M1.09M-2.87M-0.64M-0.15M2.10M
Change in Accured ExpensesChange Accured Exp.
1.57M0.80M-1.35M0.73M0.23M0.36M-1.12M0.90M1.95M-0.46M-5.05M1.00M-0.72M0.80M-2.51M2.00M0.19M1.75M-0.20M-2.32M
Other Working Capital ChangesOther WC Changes
Investing Activities
Capital ExpendituresCapex
0.31M0.06M0.01M0.00M-0.02M5.14M1.51M4.42M0.25M1.66M5.61M5.96M4.88M1.45M0.12M0.14M0.17M0.08M0.02M0.04M
Change in Acquisitions & DivestmentsChange Acquisitions
15.10M11.63M8.14M23.35M21.99M0.02M17.00M1.00M1.00M14.00M26.90M32.90M0.00M22.80M15.00M13.00M12.00M
Cash from Investing ActivitiesCash from Investing
-8.41M-14.65M-12.66M6.02M13.21M4.49M15.49M-3.42M0.75M-1.66M-5.61M-102.39M-12.58M-2.77M32.78M-11.30M7.60M14.92M-32.24M-17.90M
Financing Activities
Other financing activitiesOther financing
0.06M-0.00M0.14M0.06M-0.13M-0.15M-0.08M-2.41M3.34M0.14M67.25M100.00M0.17M0.01M0.13M0.38M5.04M-0.02M
Cash from Financing ActivitiesCash from Financing
0.35M0.11M0.20M0.06M-0.24M45.40M-0.04M-2.19M144.59M0.14M67.56M0.73M0.93M0.17M0.01M0.13M0.38M88.21M-2.92M
Change in Capital Stock
Net Shares Issued and RepurchasedNet Shares Issued
1.36M0.25M1.30M0.82M
Net Equity Issued and RepurchasedNet Equity Issued
0.29M0.11M0.06M-0.00M-0.06M0.00M-0.00M117.25M100.00M83.15M-2.90M
Additional items
Exchange Rate EffectFX Effect
-0.00M-0.01M-0.00M0.07M-0.03M0.02M
Change in Cash
-23.09M-32.43M-29.80M-7.46M1.47M-6.78M41.20M-18.17M-13.21M121.83M-27.36M-49.43M-27.95M-9.33M8.50M-30.53M-9.46M-2.33M39.87M-37.79M
Free Cash FlowFCF
-15.33M-17.95M-17.36M-13.48M-11.78M-16.16M-21.20M-19.14M-12.02M-22.76M-27.50M-20.55M-20.97M-8.95M-24.57M-19.37M-17.35M-17.79M-16.09M-17.03M
Net Cash FlowNCF
-23.09M-32.43M-29.80M-7.46M1.47M-6.78M41.20M-18.17M-13.21M121.83M-27.36M-49.43M-27.95M-9.33M8.50M-30.52M-9.46M-2.41M39.90M-37.81M